Protagonist Therapeutics (PTGX) Treasury Shares (2015 - 2025)
Protagonist Therapeutics (PTGX) reported Treasury Shares of $1.3 million for Q4 2025, up 1607.09% on a YoY basis from $75500.0 in Q4 2024, and up 1607.09% sequentially from $75500.0 in Q4 2024.
Protagonist Therapeutics (PTGX) Treasury Shares (2015 - 2025) Analysis & Trends
Protagonist Therapeutics (PTGX) has 6 years of Treasury Shares data on file, last reported at $1.3 million in Q4 2025.
- For the quarter ending Q4 2025, Treasury Shares rose 1607.09% year-over-year to $1.3 million; the trailing twelve-month figure through Dec 2025 stood at $1.3 million (up 1607.09% YoY), and the FY2025 full-year result was $1.3 million, up 1607.09% from the prior year.
- Treasury Shares rose to $1.3 million in Q4 2025, from $75500.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $1.3 million in Q4 2025 to a low of $75500.0 in Q4 2023.
- A 4-year average of $557097.4 and a median of $650612.0 in 2022 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares slumped 88.84% in 2023 and soared 1607.09% in 2025, its largest moves.
- Tracing PTGX's Treasury Shares over 4 years: stood at $694414.0 in 2022, then slumped by 89.13% to $75500.0 in 2023, then changed by 0.0% to $75500.0 in 2024, then soared by 1607.09% to $1.3 million in 2025.
- Business Quant data shows PTGX's Treasury Shares at $1.3 million in Q4 2025, $75500.0 in Q4 2024, and $75500.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Protagonist Therapeutics | 8.81 Bn | 8.81 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.29 Mn |
| Dec 31, 2025 | 1.29 Mn |
| Dec 31, 2024 | 75,500.00 |
| Dec 31, 2024 | 75,500.00 |
| Dec 31, 2023 | 75,500.00 |
| Dec 31, 2023 | 75,500.00 |
| Jun 30, 2023 | 85,500.00 |
| Jun 30, 2023 | 85,500.00 |
| Mar 31, 2023 | 864,112.00 |
| Mar 31, 2023 | 864,112.00 |
| Sep 30, 2022 | 694,414.00 |
| Sep 30, 2022 | 694,414.00 |
| Jun 30, 2022 | 766,090.00 |
| Jun 30, 2022 | 766,090.00 |
| Mar 31, 2022 | 606,810.00 |
| Mar 31, 2022 | 606,810.00 |
| Jun 30, 2016 | 124.37 Mn |
| Jun 30, 2016 | 124.37 Mn |
| Mar 31, 2016 | 2.00 Mn |
| Mar 31, 2016 | 2.00 Mn |